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Background: This study aimed to determine the associations of various clinical factors with generic health-related
quality of life (HRQOL) scores among Hong Kong Chinese patients with type 2 diabetes mellitus (T2DM) in the
outpatient primary care setting using the short-form 12 (SF-12).
Methods: A cross-sectional survey of 488 Chinese adults with T2DM recruited from a primary care outpatient clinic
was conducted from May to August 2008. Data on the standard Chinese (HK) SF-12 Health Survey and patients’
socio-demographics were collected from face-to-face interviews. Glycaemic control, body mass index (BMI), chronic
co-morbidities, diabetic complications and treatment modalities were determined for each patient through medical
records. Associations of socio-demographic and clinical factors with physical component summary (PCS-12) and
mental component summary scores (MCS-12) were evaluated using multiple linear regression.
Results: The socio-demographic correlates of PCS-12 and MCS-12 were age, gender and BMI. After adjustment for
socio-demographic variables, the BMI was negatively associated with PCS-12 but positively associated with MCS-12.
The presence of diabetic complications was associated with lower PCS-12 (regression coefficient:-3.0 points, p < 0.05)
while being on insulin treatment was associated with lower MCS-12 (regression coefficient:-5.8 points, p < 0.05). In
contrast, glycaemic control, duration of T2DM and treatment with oral hypoglycaemic drugs were not significantly
associated with PCS-12 or MCS-12.
Conclusions: Among T2DM subjects in the primary care setting, impairments in the physical aspect of HRQOL were
evident in subjects who were obese or had diabetic complications whereas defects in the mental aspect of HRQOL
were observed in patients with lower BMI or receiving insulin injections.
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The morbidity and mortality related to Type 2 diabetes
mellitus (T2DM) have been increasing worldwide over
past decades, particularly in Asia [1]. In Hong Kong,
T2DM is the second leading type of chronic disease, ac-
counting for 20% of chronic patients, with considerable* Correspondence: cfsc@hku.hk
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reproduction in any medium, provided the orprevalence of 15% in individuals aged 60–80 years [2] and
9.8% in the overall population [3].
Health-related quality of life (HRQOL) is defined as a
multidimensional construct reflecting patients’ subjective
perceptions of their physical, mental and social functioning
[4]. Meanwhile, glycaemic control describes the presence
of glucose in the blood, which is regarded as a critical out-
come of diabetes care. Failure to achieve glycaemic control
in diabetes was associated with the risks for developing
diabetic complications such as cardiovascular diseases,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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failure, and may subsequently impair the HRQOL of
T2DM patients. The impact of glycaemic control on
HRQOL was examined by previous studies in which poor
glycaemic control usually resulted in lower HRQOL as
measured by diabetes-specific and generic health preference
scores [5,6]. Besides, a higher body mass index (BMI) or
clinical obesity (BMI ≥ 30 kg/m2) was mainly associated
with a lower HRQOL [7-11]. Other factors that potentially
affect patients’ HRQOL include duration of T2DM, use of
oral hypoglycaemic drugs and insulin injections. There is
little known in Chinese patients with T2DM receiving care
in the primary care setting regarding the impact of these
clinical factors on HRQOL, as available data are limited to
the hospital-based specialist outpatient clinic setting [12,13].
Knowledge of the short-form 12 (SF-12) data is useful
for comparing the impact of T2DM with those of other
diseases and facilitating medical decision making. Never-
theless, data on the SF-12 among Hong Kong Chinese
patients with T2DM have not been reported. Hence, the
aim of this study is to report the distribution of SF-12
scores among Hong Kong Chinese patients with T2DM
and to explore the factors associated with these scores.
Methods
Study design
A cross-sectional interviewer-administered survey was
carried out at a government-funded general outpatient
clinic at Ap Lei Chau in Hong Kong China from May to
August 2008. Within the aforementioned period, there
were 1,394 patients consulting at Ap Lei Chau clinic for
T2DM. A convenience sampling of T2DM patients who
attended the clinic was retrieved from electronic med-
ical records. Selected patients were contacted prior to
their appointment dates, informed about the study and
invited to participate. On the day of their clinic visits,
patients were recruited through referrals from clini-
cians, and screened according to the inclusion and ex-
clusion criteria. The inclusion criteria were 1) diagnosis
of non-insulin dependent diabetes mellitus with an
International Classification of Primary Care-2 (ICPC-2)
code of T90 and 2) written informed consent for partici-
pation in the study. The exclusion criteria were 1) in-
ability to communicate in Cantonese or Chinese, 2)
inability to carry out activities of daily living, 3) im-
paired cognitive function as assessed by recruiter, and
4) less than one year of life expectancy due to other co-
morbidities as documented in the medical records. Data
on patients’ socio-demographics and SF-12 were col-
lected by a trained interviewer while clinical data were
retrieved from electronic medical records. The study
was approved by the Institutional Review Board of the
University of Hong Kong/Hospital Authority Hong Kong
West Cluster (HKU/HA HKW #UW 07–399).Outcome measures
Health-related quality of life
The SF-12 Health Survey is a shorter version of the 36-item
SF-36 Health Survey. It comprises 12 items that measure
physical functioning (PF), role physical (RP), role emotional
(RE), bodily pain (BP), general health (GH), vitality (VT),
social functioning (SF) and mental health (MH). The eight
domain scores were aggregated into the physical and men-
tal component summary scores (PCS-12 and MCS-12).
The summary scores of PCS-12 and MCS-12, which were
derived by the weighted sum of 12 items scores using the
US standard SF-12 scoring algorithm [14], were considered
as the primary outcomes of this study. The SF-12 has been
shown to be not only valid and reliable but also equivalent
to SF-36 in the Hong Kong population [14]. The first ver-
sion of SF-12 was used in this study. No missing data for in-
dividual items were allowed to calculate the PCS-12 and
MCS-12.
Clinical outcomes and socio-demographic information
We identified a few clinical variables that were reported to
be associated with HRQOL among T2DM patients based
on the literature [4,9,15]; these variables included gly-
caemic control, BMI, diabetic complications, hypertension,
prescription of oral hypoglycaemic drugs and insulin regi-
men. Data on glycaemic control (HbA1C) and BMI were
collected by clinical and laboratory assessments for each
patient, whereas those on duration of T2DM, presence of
T2DM-related complications (retinopathy, neuropathy,
nephropathy, cardiovascular disease and other complica-
tions caused by diabetes), type of diabetes treatment, and
presence of hypertension were extracted from medical re-
cords. In this study, retinopathy was defined as patients
with potential loss of vision (background retinopathy, pro-
liferative retinopathy or decreased vision); nephropathy
was defined as patients having proteinuria or on dialysis;
neuropathy was defined as having risk of foot ulceration,
sepsis, amputation or Charcot joints; and cardiovascular
disease was defined as having angina, previous myocardial
infarction or congestive heart failure; the presence of hyper-
tension was defined as patients with a history of hyperten-
sion in their medical record. The socio-demographic
information including marital status, education level,
monthly income and occupation was self-reported by pa-
tients. Marital status was classified as currently married or
not currently married. Educational level was categorized as
no formal, primary, secondary and tertiary schooling.
Monthly income was classified as having less than the me-
dian of HKD$20,000 (pegged at an exchange rate of USD
$1 =HKD$7.8), and having greater than or equal to HKD
$20,000. Occupation was determined through British Regis-
trar General’s classification and was classified into two cat-
egories: professional and skilled workers, and unskilled
workers and others.
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Characteristics of the study samples are described using
mean and standard deviation or proportions, where appro-
priate. As the associations of socio-demographic variables
were first evaluated followed by clinical variables, hierarch-
ical multiple linear regression was performed with PCS-12
and MCS-12 as outcome variables in separate models with
and without the adjustment for other covariates: model 1
considered socio-demographic variables (age, gender, educa-
tional level, income, marital status, and occupation); model
2 adjusted for variables in model 1 and for the clinical vari-
ables (HbA1C level, BMI level, duration of T2DM, treatment
with oral hypoglycaemic drugs, treatment with insulin, pres-
ence of diabetic complications, and presence of hyperten-
sion). In model 3, a BMI-squared term was added to test for
a potential non-linear relationship of BMI with MCS-12 and
PCS-12. The clinical and demographic variables for adjust-
ment were selected based on the conceptual framework de-
veloped by Rubin and Peyrot [4]. Duration of T2DM was
categorized into two groups (≤ 5 years or > 5 years).
Diabetes complications and hypertension were coded as
present/absent. Treatments with oral hypoglycaemic drugs
were coded as yes/no and likewise for treatment with in-
sulin. Results from all regression models were presented
with goodness-of-fit statistics in which R2 and adjusted R2
indicate the variance of PCS-12 and MCS-12 explained by
the variables. It was hypothesized that PCS-12 and MCS-
12 would be higher in patients with good glycaemic con-
trol, lower BMI, shorter disease duration, absence of DM
complications or comorbidities, and being on oral rather
than insulin treatment. The overall PCS-12 and MCS-12
scores in the current study were compared to those scores
reported in a previous population-based survey [16], using
independent t-test.
Patients with incomplete data on any of the variables
used in multiple linear regressions were excluded from
the analyses. All data analyses were performed in the
SPSS Programme for Window 20.0 (IBM SPSS Inc.
Chicago, IL, USA). P-values < 0.05 were defined as statisti-
cally significant.
Results
The characteristics of study participants are summarized
in Table 1. Mean age was 65.3 (SD: 11.0) years. Majority
were female (62.1%), did not have formal education
(40.6%), were married (72.7%), were semi-skilled workers
(29.3%), and had a monthly income less than HKD
$20,000 (70.7%).
The mean of HbA1c levels of subjects was 7.4% (SD:
1.3), with 53.5% having HbA1c > 7% and with more than
10% controlling T2DM badly (ie, with HbA1c > 9%). The
mean duration of diabetes for patients was 7.1 (SD: 6.3)
years, and the mean BMI was 25.8 kg/m2and 53.01% had
BMI ≥ 25 kg/m2. More than half of the patients (78.1%)had hypertension, and on the other hand, 90.0% of pa-
tients did not have any diabetes-related complication.
Descriptive statistics and clinical group comparisons PCS
and MCS are presented in Table 2. Patients with chronic
co-morbidities had less PCS-12 (42.00 ± 9.76 vs 46.52 ±
9.05) than patients without chronic co-morbidity. Presence
of hypertension (44.99 ± 9.30 vs 41.74 ± 9.80) and diabetic
complications (38.07 ± 11.01 vs 42.94 ± 9.52) were individu-
ally associated with poorer PCS-12. The PCS-12 was statis-
tically lower in subjects treated with oral hypoglycaemic
drugs (41.78 ± 9.77) than in subjects without oral medica-
tions (44.68 ± 9.52). Patients on insulin treatment had a sig-
nificantly lower MCS-12 score, which further substantiates
previous reports [12,17] of the adverse effect of insulin in-
jections on HRQOL.
Table 3 shows the results from multiple linear regression
analyses of HRQOL associated clinical factors, before
(model 1) and after adjustment (model 2) for socio-
demographic factors. Among all the socio-demographic fac-
tors studied, age and gender were significantly associated
with both measures of PCS-12 and MCS-12 in all regression
analyses. Based on model 2 which had adjusted for socio-
demographic factors, the association of BMI with HRQOL
was different in terms of PCS-12 and MCS-12. Significant,
positive association was found between BMI and MCS
whereas negative association was observed for PCS. Patients
on insulin treatment reported significantly worse MCS-12
with more than 5.8 points decline. The presence of DM
complications imposed a substantial negative impact on
PCS-12, while hypertension was not significantly associated
with HRQOL. HbA1C level, duration of T2DM and treat-
ment with oral hypoglycaemic drugs were not significantly
associated with PCS-12 or MCS-12. No evidence of a non-
linear effect of the BMI was found, as the BMI-squared term
was not significant and small changes of adjusted R2 (PCS-
12: -0.001; MCS-12: 0.010) from model 2 to model 3 were
reported for PCS-12 and MCS-12 analysis when it was
added to model 3.
Table 4 compares the PCS-12 and MCS-12 results be-
tween the study and general population. The mean PCS-
12 score of the study participants was significantly lower
than that of the general population (42.45 ± 9.78 vs
49.99 ± 9.23, p < 0.05). The mean MCS-12 scores were
comparable between the two populations (51.64 ± 6.37
vs 50.11 ± 9.53).
Discussion
Here we reported the first study that demonstrated the value
of generic instrument SF-12 in assessing HRQOL in
Chinese T2DM patients and examined the associated
clinical and socio-demographic factors. Generic HRQOL
instrument like SF-12 is sensitive to detect significant
differences in HRQOL scores between different socio-
demographic factors of age and gender in Hong Kong
Table 1 Characteristics of study participants (n = 488)
Duration of T2DM
Total ≤5 years (n = 265) >5 years (n = 223) P-value
Age (years, mean ± SD) 65.34 ± 11.03 64.02 ± 11.63 66.90 ± 10.08 0.004
≤54 (%) 17.0% 20.80% 12.60% <0.001
55–64 (%) 31.8% 36.2% 26.5%
≥65 (%) 51.2% 43.0% 61.0%
Gender 0.221
Male (%) 37.9% 40.4% 35.0%
Female (%) 62.1% 59.6% 65.0%
Educational Level 0.698
No Formal Education (%) 40.6% 40.0% 41.3%
Primary School (%) 33.4% 32.5% 34.5%
Secondary or above (%) 26.0% 27.5% 24.2%
Marital Status 0.768
Married (%) 72.7% 72.3% 73.5%
Non-Married* (%) 27.3% 27.7% 26.5%
Occupation 0.157
Professionals & Associate Professionals (%) 3.1% 7.9% 13.5%
Skilled Workers (%) 23.0% 24.5% 21.1%
Semi-skilled Workers (%) 29.3% 28.7% 30.0%
Unskilled Workers (%) 21.1% 23.8% 17.9%
Others (%) 16.2% 15.1% 17.5%
Monthly Income (HKD) 0.627
<$20,000 (%) 70.7% 88.3% 89.7%
≥$20,000 (%) 11.1% 11.7% 10.3%
HbA1C (%, mean ± SD) 7.38 ± 1.27 7.20 ± 1.21 7.59 ± 1.30 <0.001
BMI (kg/m2, mean ± SD) 25.79 ± 4.00 26.15 ± 4.15 25.36 ± 3.77 0.030
Drug Treatment
No Oral Hypoglycaemic Drugs (%) 23.0% 26.8% 18.4% 0.028
Oral Hypoglycaemic Drugs (%) 77.0% 73.2% 81.6%
No Insulin Injections (%) 97.7% 99.6% 95.5% 0.002
Insulin Injections (%) 2.3% 0.4% 4.5%
Any Diabetic Complications 0.430
Absent (%) 90.0% 90.9% 88.8%
Present (%) 10.0% 9.1% 11.2%
Retinopathy 3.1% 2.3% 4.0% 0.259
Neuropathy 0.8% 0.8% 0.9% 0.862
Nephropathy 2.0% 0.8% 3.6% 0.028
Cardiovascular Disease 4.5% 5.3% 3.6% 0.369
Others 0.2% 0.0% 0.4% NA
Presence of Hypertension 0.083
Absent (%) 11.9% 24.9% 18.4%
Present (%) 78.1% 75.1% 81.6%
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Table 1 Characteristics of study participants (n = 488) (Continued)
SF-12 Health Survey
PCS-12 (mean ± SD) 42.45 ± 9.78 42.96 ± 9.60 41.84 ± 9.97 0.210
MCS-12 (mean ± SD) 51.64 ± 6.37 51.70 ± 6.29 51.57 ± 6.48 0.822
BMI body mass index, HbA1c glycated haemoglobin, MCS-12 Chinese (HK) SF-12 mental component summary, PCS-12 Chinese (HK) SF-12 physical component
summary, SF-12 short-form 12, T2DM type 2 diabetes mellitus.
* Non-married includes single, widowed, separated, divorced and refusal.
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tients, our study confirmed that age and gender were asso-
ciated with both PCS-12 and MCS-12. Specifically, age was
negatively associated with PCS-12 but positively with MCS-
12, whereas female gender was negatively associated with
both measures. Similar patterns of the socio-demographicTable 2 Descriptive statistics of HRQOL scores, PCS-12 and M
N = 488
Overall (N = 488)
HbA1C (%, mean ± SD) 7.38 ± 1.27
Below Glycaemic Goal, ≤7.0 (%) 46.46%
Above Glycaemic Goal, >7.0 (%) 53.54%
BMI (kg/m2, mean ± SD) 25.79 ± 4.00
Underweight/normal, <23 (%) 22.87%
Overweight, 23 to <25 (%) 24.12%
Obese, ≥25 (%) 53.01%
Duration of T2DM (years, mean ± SD) 7.10 ± 6.27
Duration≤ 5 years (%) 54.30%
Duration > 5 years (%) 45.70%
Lifestyle
No Diet (%) 18.03%
Diet (%) 81.97%
No Exercise (%) * 23.16%
Exercise (%) * 76.84%
Drug Treatment
No Oral Hypoglycaemic Drugs (%) * 22.95%
Oral Hypoglycaemic Drugs (%) * 77.05%
No Insulin Injections (%) † 97.75%
Insulin Injections (%) † 2.25%
Any Diabetic Complications
Absent (%) * 89.96%
Present (%) * 10.04%
Any Chronic Co-morbidities
Absent (%) * 9.84%
Present (%) * 90.16%
If present, how many (mean ± SD) 1.87 ± 0.98
Note:BMI body mass index, HbA1c glycated haemoglobin, MCS-12 Chinese (HK) SF-1
summary, SF-12 short-form 12, T2DM type 2 diabetes mellitus
* Significant difference (p < 0.05) on PCS-12 between groups by independent samp
† Significant difference (p < 0.05) on MCS-12 between groups by independent sampfactors on HRQOL were captured by a survey with refer-
ence to Chinese professional drivers in Hong Kong [13].
BMI was the only significant clinical predictor of both
PCS-12 and MCS-12 in our multivariate analyses, after ac-
counting for socio-demographic and clinical factors. Previ-
ous findings showed that obesity impaired physical healthCS-12 by clinical characteristics
PCS-12 MCS-12
Mean ± SD P-value Mean ± SD P-value
42.45 ± 9.78 51.64 ± 6.37
41.89 ± 9.94 0.222 51.56 ± 6.20 0.793
42.99 ± 9.69 51.72 ± 6.46
43.46 ± 10.18 0.196 50.53 ± 7.36 0.110
43.17 ± 9.41 52.15 ± 6.00
41.71 ± 9.75 51.89 ± 6.10
42.96 ± 9.60 0.210 51.70 ± 6.29 0.822
41.84 ± 9.97 51.57 ± 6.48
43.01 ± 9.94 0.550 51.62 ± 6.54 0.978
42.32 ± 9.75 51.65 ± 6.34
40.48 ± 9.26 0.015 50.97 ± 6.74 0.200
43.04 ± 9.86 51.84 ± 6.25
44.68 ± 9.52 0.006 51.10 ± 6.69 0.307
41.78 ± 9.77 51.80 ± 6.27
42.54 ± 9.69 0.182 51.76 ± 6.25 0.007
38.55 ± 12.95 46.57 ± 9.57
42.94 ± 9.52 0.001 51.63 ± 6.33 0.898
38.07 ± 11.01 51.75 ± 6.80
46.52 ± 9.05 0.002 50.67 ± 7.09 0.268
42.00 ± 9.76 51.75 ± 6.29
2 mental component summary, PCS-12 Chinese (HK) SF-12 physical component
les t-test.
les t-test.
Table 3 Clinical and socio-demographic factors associated with PCS-12 and MCS-12 by Hierarchical Multiple
Linear Regression
PCS-12 MCS-12
Coeff. 95% CI P-value Coeff. 95% CI P-value
Model 1 (R2 = 0.216; Adj R2 = 0.206) Model 1 (R2 = 0.035; Adj R2 = 0.023)
Socio-demographic Socio-demographic
Age −0.29 (−0.37,−0.20) <0.001* Age 0.07 (0.01,0.13) 0.020*
Female −3.50 (−5.39,−1.60) <0.001* Female −1.60 (−2.96,−0.24) 0.021*
Educational (No formal education) Educational (No formal education)
Secondary or above 1.76 (−0.61,4.13) 0.145 Secondary or above −0.89 (−2.59,0.81) 0.304
Primary School −0.91 (−2.93,1.10) 0.374 Primary School −2.04 (−3.49,−0.59) 0.006*
Married 1.56 (3.49,−0.37) 0.114 Married 0.09 (1.48,−1.29) 0.894
Professional and Skilled 1.11 (−0.79,3.02) 0.253 Professional and Skilled 0.47 (−0.90,1.83) 0.505
Monthly Income ≥ HKD$20,000 1.14 (−1.51,3.79) 0.399 Monthly Income ≥ HKD$20,000 0.93 (−0.97,2.83) 0.338
Model 2 (R2 = 0.252; Adj R2 = 0.229) Model 2 (R2 = 0.074; Adj R2 = 0.045)
Socio-demographic Socio-demographic
Age −0.30 (−0.38,−0.21) <0.001* Age 0.09 (0.03,0.15) 0.005*
Female −3.48 (−5.36,−1.60) <0.001* Female −1.73 (−3.08,−0.39) 0.012*
Educational (No formal education) Educational (No formal education)
Secondary or above 1.11 (−1.25,3.47) 0.358 Secondary or above −0.54 (−2.24,1.15) 0.530
Primary School −1.28 (−3.30,0.73) 0.211 Primary School −1.79 (−3.23,−0.35) 0.015*
Married 1.46 (−0.44,3.36) 0.133 Married 0.23 (−1.13,1.60) 0.736
Professional and Skilled 1.09 (−0.80,2.97) 0.259 Professional and Skilled 0.63 (−0.72,1.99) 0.361
Monthly Income ≥ HKD$20,000 1.11 (−1.50,3.72) 0.405 Monthly Income ≥ HKD$20,000 0.92 (−0.95,2.79) 0.333
Clinical Clinical
HbA1C 0.05 (−0.58,0.68) 0.872 HbA1C 0.06 (−0.39,0.51) 0.801
BMI −0.28 (−0.49,−0.08) 0.006* BMI 0.15 (0.00,0.29) 0.048*
Duration of DM >5 years −0.25 (−1.86,1.36) 0.763 Duration of DM >5 years −0.05 (−1.21,1.10) 0.931
Oral Hypoglycaemic Drug 0.56 (−2.51,3.64) 0.719 Oral Hypoglycaemic Drug −1.09 (−3.29,1.12) 0.334
Insulin Injection −3.79 (−9.02,1.45) 0.156 Insulin Injection −5.80 (−9.56,−2.05) 0.002*
DM complications −3.04 (−5.66,−0.42) 0.023* DM complications 0.31 (−1.57,2.19) 0.743
Hypertension −1.55 (−4.67,1.57) 0.330 Hypertension 1.99 (−0.25,4.23) 0.082
Model 3 (R2 = 0.252; Adj R2 = 0.228) Model 3 (R2 = 0.085; Adj R2 = 0.055)
Socio-demographic Socio-demographic
Age −0.30 (−0.38,−0.21) <0.001* Age 0.09 (0.03,0.15) 0.005*
Female −3.56 (−5.45,−1.66) <0.001* Female −1.81 (−3.17,−0.45) 0.009*
Educational (No formal education) Educational (No formal education)
Secondary or above 1.10 (−1.26,3.46) 0.362 Secondary or above −0.55 (−2.25,1.14) 0.521
Primary School −1.31 (−3.33,0.70) 0.201 Primary School −1.82 (−3.26,−0.38) 0.013*
Married 1.43 (−0.47,3.34) 0.140 Married 0.21 (−1.16,1.57) 0.765
Professional and Skilled 1.04 (−0.85,2.94) 0.279 Professional and Skilled 0.59 (−0.77,1.94) 0.396
Monthly Income≥ HKD$20,000 1.14 (−1.47,3.74) 0.393 Monthly Income≥ HKD$20,000 0.95 (−0.92,2.82) 0.318
Clinical Clinical
HbA1C 0.06 (−0.57,0.68) 0.863 HbA1C 0.06 (−0.39,0.51) 0.788
BMI −0.80 (−2.42,0.82) 0.334 BMI −0.39 (−1.55,0.77) 0.508
BMI2 0.01 (−0.02,0.04) 0.529 BMI2 0.01 (−0.01,0.03) 0.358
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Table 3 Clinical and socio-demographic factors associated with PCS-12 and MCS-12 by Hierarchical Multiple
Linear Regression (Continued)
Duration of DM >5 years −0.24 (−1.85,1.37) 0.767 Duration of DM >5 years −0.05 (−1.20,1.11) 0.937
Oral Hypoglycaemic Drugs 0.59 (−2.48,3.66) 0.706 Oral Hypoglycaemic Drugs −1.06 (−3.26,1.14) 0.346
Insulin Injections −3.82 (−9.05,1.42) 0.153 Insulin Injections −5.83 (−9.59,−2.08) 0.002*
DM complications −3.04 (−5.66,−0.42) 0.023* DM complications 0.31 (−1.56,2.19) 0.743
Hypertension −1.46 (−4.59,1.67) 0.361 Hypertension 2.08 (−0.16,4.33) 0.069
Note: BMI body mass index, HbA1c glycated haemoglobin, HT Hypertension, MCS-12 Chinese (HK) SF-12 mental component summary, PCS-12 Chinese (HK) SF-12
physical component summary, SF-12 short-form 12, T2DM type 2 diabetes mellitus.
*Significant difference (p < 0.05) on regression coefficient.
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[10]. According to a review by Kushner et al. [19], more
severe types of obesity should in general have negative im-
pacts on both physical and mental aspects of HRQOL,
which was opposite to our result that lower BMI levels
were consistently associated with lower MCS-12, but not
with lower PCS-12. These completely different effects of
BMI on PCS-12 and MCS-12 were also reported in other
studies [13], in line with the ‘jolly fat’ hypothesis [20] indi-
cating obese subjects perceived better mental aspect of
HRQOL. Even when the univariate analysis appeared to
show a non-linear relationship of BMI with MCS-12, the
multivariate analyses did not provide evidence for a non-
linear relationship as the coefficient before BMI-squared
term is not significant for MCS-12 or PCS-12 in addition
to the small change in adjusted R2 between models with
and without BMI-squared term.
This study demonstrated the contrary associations of
BMI with physical and mental aspects of HRQOL, and
urged caution on the statement that lower BMI in
T2DM subjects was associated with better HRQOL re-
gardless of physical and mental aspects. Our finding also
points to an unmet need in patient education – a lack of
self-discipline in diet and physical activity among over-
weight/obese patients may account for their seemingly
better mental health and compromised physical health
compared with patients with a lower BMI. In educating
these patients, it is important for clinicians to highlight
the negative impacts of obesity on physical health, in
order to motivate patients to implement necessary life-
style modifications. Building a social supportive network
is a feasible approach to improving patients’ psycho-
social health, and reinforcing their motivation to main-
tain a healthy lifestyle.Table 4 Comparison of PCS-12 and MCS-12 results from Chin
SF-12 Summary Scores Present study (n = 48
PCS-12* (mean ± SD) 42.45 ± 9.78
MSC-12 (mean ± SD) 51.64 ± 6.37
Note: MCS-12 Chinese (HK) SF-12 mental component summary, PCS-12 Chinese (HK
*Significant difference (p < 0.05) between studies by independent samples t-test.Diabetic complications and insulin injection treatment
were two predictors of poor HRQOL identified in our
study. Several studies showed [8,21-23] that the increase in
the number of diabetic complications would lead to im-
pairment of PCS-12 and generic health preference scores.
There is little evidence that injection regimen would be
beneficial to HRQOL of T2DM patients. Two UK studies
found that compared with oral hypoglycaemic drug treat-
ment alone, insulin injection treatment significantly im-
proved patients’ subjective well-being [24], in particular, at
the expense of a higher degree of anxiety [25]. Our study
provided evidence on the deterioration of mental HRQOL
upon injection regimen. Moreover, our study demonstrated
that glycaemic control and duration of T2DM were not
significantly associated with HRQOL in patients with
T2DM, in contrast to the conventional perception that gly-
caemic control was an important determinant of quality of
life as reported in previous studies [5,26,27]. Another
study conducted in Hong Kong also reported a lack of
association between HRQOL with glycaemic control
and duration of T2DM, suggesting that this might be a
culturally-specific finding [12]. Another reason was the
adaption of generic instruments to measure HRQOL.
Generic instruments provided more information on
daily living and functioning related to quality of life
rather than lifestyle and dietary issues [28-30] whereas
diabetic-specific HRQOL instruments measured the
quality of life impacted by diabetes. By convention,
generic instruments were recommended for use in
conjunction with diabetic-specific HRQOL instru-
ments because diabetic-specific instruments would be
more responsive to changes in quality of life scores be-
tween good and bad glycaemic control, compared with
generic HRQOL instruments [4,28,31]. While disease-ese Hong Kong Population
8) 2008-2009 HK general population study (n = 2,533)
49.99 ± 9.23
50.11 ± 9.53
) SF-12 physical component summary, SF-12 short-form 12.
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http://www.hqlo.com/content/11/1/142specific measures offer greater sensitivity and respon-
siveness compared with generic measures of HRQOL,
generic measures allow for comparing the impact of
diseases on HRQOL across various diseases and are
more useful for guiding resource allocation. Both gen-
eric and disease-specific HRQOL measures would be
used in tandem, with consideration of study objectives
and patient burden [4].
There were several limitations for this study. First, cau-
tion is warranted that only association but not causality
could be established by this cross-sectional study. Conveni-
ence sampling also limits the representativeness of the
study sample. For example, insulin users who are frequently
managed in secondary care may be under-represented in
our study. Secondly, the health behavioural factors (e.g.
smoking, drinking, diabetes self-management activities) and
non-vascular diseases (e.g. musculoskeletal and emotional
disorders) were not controlled for in the multivariate ana-
lyses. Regular physical exercise, as the highest positive indi-
cator in the PCS-12 score, might be affected by those health
behavioural factors. Further investigations are warranted to
explore whether the associations of the clinical variables
with HRQOL are medicated or partly mediated by these
lifestyle factors. Thirdly, DM complications and chronic
co-morbidities were recorded as numbers if present, with-
out grading the severity of each complications and co-
morbidities. Further studies on stratifying the severity of
complications, e.g. into macrovascular and micro-vascular
complications, are warranted, as suggested by previous
studies [21,27,32]. Fourthly, the number of insulin users in
this study was small (n = 11), as quality of life scores were
not documented for insulin users with or without combin-
ational treatment. Further studies are required to prove the
impact of diabetic symptoms, behavioural and psycho-
logical factors on both generic and diabetic-related HRQOL
instruments regarding Chinese patients with T2DM. Fi-
nally, the response rate of this study was not reported be-
cause the reasons for non-participation and number of
subjects who were approached but declined to participate
were not recorded in the data collection process.
Conclusions
This study suggested that for patients with T2DM, obes-
ity and diabetic complications affected their physical
HRQOL, while insulin injections affected patients’ men-
tal HRQOL, informing the deficiency of HRQOL as a
barrier to optimal diabetes management and control in
primary care settings in Hong Kong.
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